📩 Get the latest developments in clinical supply chain & logistics delivered to your inbox weekly: https://lnkd.in/d6NKbrNt Clinical Supply Leader will help you pinpoint inefficiencies in your supply chain, stay up to date on regulatory changes, identify potential supplier partners, and much more. Join our community today!
Clinical Supply Leader
Internet Publishing
Cranberry Township, Pennsylvania 946 followers
A trusted source for those professionals ensuring a secure clinical supply chain from drug development to post-trial.
About us
Clinical Supply Leader is a Life Science Connect community dedicated to facilitating seamless collaboration between key functional roles at the intersection of the clinical trial supply chain and logistics. With a primary focus on clinical operations and supply chain experts, we understand that these disciplines must collaborate to ensure the success of clinical supply management. Our community is committed to being a resource for tailored expertise and valuable insights curated to empower those entrusted with the secure, precise, and punctual delivery of life-saving treatments to patients at their respective clinical sites. We also emphasize the efficient management of product returns, reconciliation, and disposal, ensuring every aspect of the clinical supply chain is addressed securely. From the earliest stages of drug development to the intricacies of post-trial processes we cover all aspects of the clinical supply chain and logistics, from the early stages of drug development to post-trial processes.
- Website
-
https://www.clinicalsupplyleader.com/
External link for Clinical Supply Leader
- Industry
- Internet Publishing
- Company size
- 51-200 employees
- Headquarters
- Cranberry Township, Pennsylvania
- Specialties
- life sciences, clinical supply, clinical supply chain, and clinical supply logistics
Updates
-
For preclinical or early-stage biopharma companies developing cell or gene therapies, selecting the right CDMO is critical to ensure future success. Explore CDMO selection for early-stage biopharma, including criteria to consider during the CDMO selection process. https://lnkd.in/e7u5YB5Y By Steve Kornher, Halloran Consulting Group, Inc., a PLG company
Key Considerations For Early-Stage CGT Companies When Selecting A CDMO
clinicalsupplyleader.com
-
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster. https://lnkd.in/eb8VMQQa Source: West Pharmaceutical Services
Packaging For Biopharma: Navigating Primary Packaging Challenges And Solutions For Emerging Innovators
clinicalsupplyleader.com
-
Clinical Supply Leader reposted this
Join us TOMORROW (December 18th) to gain the basic knowledge for developing a continuous chromatography process using Simulated Moving Bed Technology (SMB) for small molecule chiral and non-chiral applications from gram to commercial multi-ton quantities. 📌 Reserve your spot for the discussion: https://lnkd.in/d4dK2xRi Through examples, Olivier Dapremont of SK pharmteco will demonstrate the benefits of the SMB technology: ◽ Rapidity of the development ◽ Easy scale-up ◽ cGMP compliant for API manufacturing ◽ Cost effective compared to other techniques ◽ Superior sustainability advantage through recycling strategies
-
-
With renewed momentum around EMA’s ISO Identification of Medicinal Products (#IDMP) implementation in Europe, FDA’s own related plans in the U.S., as well as cross-industry initiatives, MAIN5 recently partnered with Pistoia Alliance and data registry specialist ACCURIDS to conduct new benchmark research to determine companies’ latest progress and planning around IDMP implementation. https://lnkd.in/eaHwaGyG By Michiel Stam, MAIN5
Survey Findings: How Are IDMP Readiness Efforts Progressing?
clinicalsupplyleader.com
-
While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges. Should your risk analysis start from a blank piece of paper for each trial? https://lnkd.in/eGbYt6cE Source: Perceptive Inc.
How Long Is Your RTSM Risk Mitigation List?
clinicalsupplyleader.com
-
AstraZeneca is packing in the latest technology at its APICOM facility in Dublin. A key feature is more effective and timely use of process data. Simon Capewell gave us a preview and answered questions about the specific technology they’re using and other aspects of the project. https://lnkd.in/ek6apxsZ
AstraZeneca's Digitally Connected Strategy For API Manufacturing
clinicalsupplyleader.com
-
Clinical Supply Leader reposted this
WEBINAR NEXT WEEK! Join us on December 18th to gain the basic knowledge for developing a continuous chromatography process using Simulated Moving Bed Technology (SMB) for small molecule chiral and non-chiral applications from gram to commercial multi-ton quantities. 🔐 Secure your spot for the discussion: https://lnkd.in/eFD82NDW Through examples, Olivier Dapremont of SK pharmteco will demonstrate the benefits of the SMB technology: ◽ Rapidity of the development ◽ Easy scale-up ◽ cGMP compliant for API manufacturing ◽ Cost effective compared to other techniques ◽ Superior sustainability advantage through recycling strategies
-
-
Best of November 🥇 View last month's most read articles on clinical supply chain and logistics! https://lnkd.in/eshWTyqm Tony Hitchcock, AGH Bioconsulting | Perceptive Inc. | Donnie Beers, Ike Young, BioPhorum | Signant Health | Christopher Ohms, Ohms Consulting
Best of November: Top 5 Insights In Clinical Supply Chain & Logistics
clinicalsupplyleader.com
-
Clinical Supply Leader reposted this
🚨 Don't miss tomorrow's discussion! Join us on December 12th to discover how it’s possible to tailor RTSM to meet specific precision medicine challenges of expiry, visit & personalized shipment management. 🔐 Secure your spot: https://lnkd.in/dTYD4ED7 Through real-world case studies, Perceptive Inc.'s Malcolm Morrissey will explore: ◽ Effective support for cell and gene therapy (CGT) and radiopharmaceutical studies ◽ Solutions for oncology and rare disease trials, adaptive and master protocols, and just-in-time sourcing ◽ Strategies for managing high unblinding risks and medication pooling
-